The Pharmacokinetics/Pharmacodynamic Relationship of Durlobactam in Combination With Sulbactam in In Vitro and In Vivo Infection Model Systems Versus <i>Acinetobacter baumannii-calcoaceticus</i> ComplexJohn P. O’Donnell, Sujata M. Bhavnani|Clinical Infectious Diseases|2023Cited by 32
Zoliflodacin versus ceftriaxone plus azithromycin for treatment of uncomplicated urogenital gonorrhoea: an international, randomised, controlled, open-label, phase 3, non-inferiority clinical trialAlison Luckey, Henry J.C. de Vries, Jodie Dionne‐Odom et al.|The Lancet|2025Cited by 26
Effect of food on the pharmacokinetics of zoliflodacin granules for oral suspension: Phase I <scp>open‐label</scp> randomized cross‐over study in healthy subjectsAlison Luckey, Jean‐Yves Gillon, Emilie Alirol et al.|Clinical and Translational Science|2023Cited by 6
P-1251. Pharmacometric Analyses to Support Dose Selection of Zoliflodacin, a First-in-Class Oral Antibiotic Being Developed for the Treatment of Uncomplicated GonorrheaSujata M. Bhavnani, Christopher M. Rubino, Anthony P Cammarata et al.|Open Forum Infectious Diseases|2025Cited by 4